Navigation Links
Analog Devices Healthcare Team Participates in MIT Forum on Medical Device Industry : ADI's healthcare technology experts Patrick O'Doherty and Tom O'Dwyer offer insights on trends impacting next-generation medical electronic systems.
Date:12/5/2008

nufacturers are being challenged to develop highly integrated chips that will provide the enabling technology for next-generation medical devices, including increasingly lighter and smaller portable medical devices."

As an example, O'Doherty discussed two eight-channel (octal) ultrasound receivers recently introduced by ADI. One offers the industry's lowest terminated noise for high- and mid-end cart-based ultrasound equipment that needs superior image quality, and the other is the most power-efficient device in its class for addressing the requirements of portable ultrasound systems. Both are examples of the highest level of integration available to ultrasound system manufacturers, with many key functions previously only available in discrete form, now provided on a single chip and designed to optimize ultrasound system performance.

Tom O'Dwyer took part in a panel discussion that focused on the topic, "The Next Semiconductor Opportunity: Medical Electronics and Systems." O'Dwyer and other medical electronics experts discussed state-of-the-art semiconductor technology as well as significant emerging trends affecting the design of new medical devices. Topics covered included ultra-low-power device and system design, system requirements and specifications, emerging applications, market opportunities and component technologies.

About Patrick O'Doherty

As healthcare segment director at Analog Devices, Patrick O'Doherty leads the company's business development and marketing efforts for technology that enables prevention, detection, diagnosis and treatment of a variety of human conditions. O'Doherty oversees ADI's dedicated healthcare team that works to complement the ongoing efforts of ADI's many existing product lines and field resources already successfully focused on healthcare. His responsibilities include managing the design, sales, and marketing teams responsible for developing signal chain solut
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TIs Portfolio of Embedded Processors and Analog Products
2. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
3. Video: TI unveils industrys first family of complete analog front ends for superior ultrasound systems
4. Varian, Inc. Acquires Analogix Business
5. Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices
6. Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group : MPAnalytics, a Medical Consultant Group, Provides Market Analysis and Guidance for New Medical Devices, Technology, and Clinical Trial Protocol
7. MP3 Player Headphones May Throw Off Cardiac Devices
8. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
9. InHealth awards grants to study impact of medical diagnostics and devices on patients, health care
10. New Vascular Access Medical Devices Launched by Navilyst Medical
11. NitiBrite™ - Break-through in Nitinol Wire Product for Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Analog Devices Healthcare Team Participates in MIT Forum on Medical Device Industry :  ADI's healthcare technology experts Patrick O'Doherty and Tom O'Dwyer offer insights on trends impacting next-generation medical electronic systems. 
(Date:8/23/2014)... (PRWEB) August 23, 2014 GranuFlo ... 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue ... in U.S. District Court, District of Massachusetts, Bernstein ... report issued by the U.S. Judicial Panel on ... 2,028 claims are pending in the proceeding. In ...
(Date:8/23/2014)... 2014 According to the new ... Application and Geography - Regional Trends & Forecast ... Market with an analysis and forecast of value ... of electronic adhesives by applications and geography are ... market data tables and 26 figures spread through ...
(Date:8/23/2014)... PA (PRWEB) August 23, 2014 "When ... sometimes comes into contact with the dirty water inside ... the seat itself," said one of two inventors from ... to germs, we developed this protective device." , They ... unsanitary toilet surfaces, including the water, bowl and seat. ...
(Date:8/23/2014)... 2014 Hundreds of Wright hip ... of individuals who were allegedly harmed by devices ... to move forward in the U.S. District Court, ... According to an Order dated August 19th, the ... would allow the litigation’s first case to go ...
(Date:8/23/2014)... York, NY (PRWEB) August 23, 2014 ... (NYT) reported on a data breach suffered by ... that saw the compromise of 4.5 million records containing ... social security numbers. According to Mandiant, who was engaged ... emanated from an advanced group of cyber attackers ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 4Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4
... led by Dr. Bernhard Hering have reported the arrival of ... new $6.2 million, 21,000-square-foot Islet Resource Facility in Minneapolis, U.S. ... project- the Spring Point Project, a non- profit organization for ... ,This project will focus on the testing of ...
... 36-year-old professional body-builder who used growth hormone to boost his ... to a report. ,He was admitted with chest ... 12 months, during which he had also experienced excessive urination, ... for 15 years and artificial growth hormone for the past ...
... - The FDA has permitted the use of a ... drug known as Vyvanse//, is manufactured by Shire PLC. ... have a smooth transition from the older ADHD medications ... that the present drug is promising because it is ...
... doctors in Srinagar are quite frustrated by the large number ... bite cases// recorded by the main SMHS hospital here last ... in the last two months. 'The situation is alarming. We ... cases the victims are suspected to have been bitten by ...
... are under the impression that ovarian cancer can be detected ... that this wrong notion is more dangerous to the lives ... 610 women, out of which 305 thought that pap smear ... Breast Cancer Centre said that pap smear is not the ...
... education programme on cervical cancer prevention and the new vaccine ... organized by a team of doctors from Obstetrics and Gynecology ... ,Dr Rihab Awad of the hospital insisted on ... tests once a year. Any aberration detected in cervix can ...
Cached Medicine News:Health News:Pigs Arrive at Bio-secure Center 2
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... , Aug. 21, 2014 Nektar ... International Inc. today announced positive results from its ... an investigational, extended half-life recombinant factor VIII (rFVIII) ... Factor (Recombinant)], which met its primary endpoint in ... arm compared to the on-demand arm. ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... Johnson & Johnson Pharmaceutical,Research & Development, ... demonstrate doripenem (DORIBAX(TM), doripenem for injection), a,carbapenem ... in vitro against certain,strains of Enterobacteriaceae, including ... Enterobacteriaceae is a large group of ...
... A doctor who is,internationally recognized for her ... DHA, an omega-3 fatty acid, has received the,March ... in the field,of maternal-fetal nutrition., Susan E. ... that infants,receiving breast milk had higher DHA (dietary ...
Cached Medicine Technology:New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 2New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 3New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 4New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 5March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition 2
Platelet agitator....
I-125 competitive RIA kit for the detection of Progesterone....
... quantitative determination of progesterone ... Progesterone EIA is ... of competitive binding between ... specimen and progesterone-HRP conjugate ...
ELISA for the detection of Insulin....
Medicine Products: